West Pharmaceutical Services, Inc. (WST) Stake Lifted by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership lifted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 148.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 140,913 shares of the medical instruments supplier’s stock after purchasing an additional 84,100 shares during the period. Arrowstreet Capital Limited Partnership owned 0.19% of West Pharmaceutical Services worth $13,319,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of West Pharmaceutical Services by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 6,555,351 shares of the medical instruments supplier’s stock worth $619,612,000 after purchasing an additional 114,507 shares during the last quarter. BlackRock Inc. increased its stake in shares of West Pharmaceutical Services by 7.1% during the 2nd quarter. BlackRock Inc. now owns 6,217,894 shares of the medical instruments supplier’s stock worth $587,715,000 after purchasing an additional 412,858 shares during the last quarter. State Street Corp increased its stake in shares of West Pharmaceutical Services by 2.8% during the 2nd quarter. State Street Corp now owns 2,511,108 shares of the medical instruments supplier’s stock worth $237,351,000 after purchasing an additional 67,937 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of West Pharmaceutical Services by 10.1% during the 2nd quarter. Goldman Sachs Group Inc. now owns 935,685 shares of the medical instruments supplier’s stock worth $88,441,000 after purchasing an additional 86,022 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of West Pharmaceutical Services by 1.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 853,482 shares of the medical instruments supplier’s stock worth $80,671,000 after purchasing an additional 11,166 shares during the last quarter. Institutional investors own 90.57% of the company’s stock.

Shares of West Pharmaceutical Services, Inc. (NYSE:WST) traded up 0.13% on Thursday, reaching $94.07. 113,459 shares of the company were exchanged. West Pharmaceutical Services, Inc. has a 12-month low of $70.17 and a 12-month high of $99.91. The firm has a market capitalization of $6.96 billion, a PE ratio of 40.37 and a beta of 1.12. The company’s 50 day moving average is $91.92 and its 200 day moving average is $91.09.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, beating the consensus estimate of $0.65 by $0.01. The company had revenue of $397.60 million during the quarter, compared to analysts’ expectations of $406.00 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. West Pharmaceutical Services’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.59 earnings per share. Analysts forecast that West Pharmaceutical Services, Inc. will post $2.68 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 1st. Investors of record on Wednesday, October 18th will be paid a dividend of $0.14 per share. The ex-dividend date is Tuesday, October 17th. This represents a $0.56 annualized dividend and a yield of 0.60%. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. West Pharmaceutical Services’s payout ratio is currently 22.22%.

COPYRIGHT VIOLATION WARNING: “West Pharmaceutical Services, Inc. (WST) Stake Lifted by Arrowstreet Capital Limited Partnership” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.themarketsdaily.com/2017/10/12/west-pharmaceutical-services-inc-wst-stake-lifted-by-arrowstreet-capital-limited-partnership.html.

WST has been the topic of a number of research reports. Stephens initiated coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price target on the stock. Zacks Investment Research lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. BidaskClub lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Finally, Jefferies Group LLC upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and upped their price target for the company from $96.00 to $115.00 in a research note on Friday, September 15th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $107.00.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply